University of California San Francisco
Give to UCSF
Displaying 1 - 30 of 1219
-
-
Has Science Cracked the Code on Chronic Pain?
In a first, researchers have identified chronic pain pathways in individuals directly from their neural activity, showing promising paths forward for treatment.
-
Two UCSF Faculty Named to New Group of HHMI Scholars
UCSF faculty members Walter G. Gonzalez and Angela Phillips have been selected as Howard Hughes Medical Institute (HHMI) Freeman Hrabowski Scholars. With up to $8.6 million in support, they will conduct research, create inclusive lab environments, and make a significant impact on the future of science. Both scholars are committed to fostering diversity and promoting scientific breakthroughs.
-
Does Your Vaccine Type Matter in the Battle Against COVID?
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.
-
UCSF Researchers Study Degrees of COVID-19 Vaccine Protection
-
UCSF Diabetes Center Founder Elected to National Academy of Sciences
Immunologist and UCSF Professor Emeritus Jeffrey Bluestone, PhD, has been elected to the National Academy of Sciences (NAS) – one of the highest honors bestowed on American scientists.
-
UCSF is First in California to Provide Drug-Gene Testing
UCSF is the first hospital in California to offer pharmacogenetic testing for smarter prescribing. Testing identifies genetic makeup and tailors medications to improve efficacy and avoid lethal drug reactions.
-
How 3D Printer Heart Technology Changed a Teen’s Life
From birth, Samantha has had four surgeries for heart disease. Her last surgery was aided by a 3D-printed replica of her heart, providing a detailed understanding of her heart’s anatomy. The surgery’s success allowed the now 15-year-old to lead a more normal life.
-
Possible Culprit Identified in Outbreak of Severe Liver Damage Cases in Children
-
Severe Hepatitis Outbreak Linked to Common Childhood Viruses
A hepatitis outbreak in children occurred after COVID-19 lockdowns eased in 2022. Sudden exposure to a multitude of viruses upon reopening may have triggered this response in a small group of children.
-
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
-
Bad Company: Is Too Much Alone Time Making You Sick?
What is “social prescribing” and what is UCSF doing to promote it? UCSF experts address the health ramifications of social isolation.
-
White House Disbanding Its COVID-19 Team in May
-
If You Still Haven’t Had COVID, Are You Immune – Or Just Lucky?
-
Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
-
New App Calculates Women’s Risk for Advanced Breast Cancer
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
-
UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UCSF’s Heart and Vascular Center participation in a new Cardiogenic Shock Registry aims to improve treatment for cardiogenic shock types.
-
Susceptibility to Pathogenic T Cells in Chronic Lung Disease May Have Genetic Basis
Respiratory viral infections pose significant morbidity and mortality to patients with chronic lung diseases like emphysema and COPD, causing exacerbations that drive destruction of normal lung tissue
-
When Can I Get a Second Bivalent COVID Booster? Here’s What We Know Right Now
-
How to Improve COVID Vaccination Rates With Emergency Room Messaging
UCSF researchers found that distributing pro-COVID-19 vaccine information in EDs in English and Spanish increased vaccine acceptance, especially among Latinos and those without primary care physicians.
-
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
-
Even a Brain-Eating Amoeba Can’t Hide From This Cutting-Edge Diagnosis Tech
-
Here’s Why You Should Start Taking Seasonal Allergy Meds Sooner Than You Think
-
Can We Turn Back Time on Age-Related Diseases?
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
-
The Omicron Effect: Can We Predict the Next Viral Killer?
Angela Phillips, PhD, leads research that could help predict future viruses like COVID and the antibodies we might use to treat them.
-
If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
-
What We Were Taught About RNA in High School is Only Half the Picture
Vissers’ work on RNA tags helped found the field of epitranscriptomics, the study of how chemical marks on RNA, rather than their sequence alone, dictate the function of the molecules.
-
Breaking the Code on Dangerous Lung Inflammation
When we inhale an airborne virus, our lung cells take on the role of immune system first responders. Catera Wilder, PhD, studies the molecular details of this response and how it can go awry, causing the body to damage its own tissue and cells.
-
Researchers Receive High Honors for Outstanding Science Contributions
Three UCSF researchers were named 2022 fellows by the American Association for the Advancement of Science (AAAS), one of the highest honors in science.
-
Should You ‘Forever’ Mask in Some Settings? Here’s What UCSF’s Bob Wachter and Other COVID Experts Are Doing